Breast cancer
Results
Phase 2
This study looked at irosustat for women who had been through the menopause and had early stage, oestrogen receptor positive (ER positive) breast cancer.
Recruitment start: 14 August 2012
Recruitment end: 26 November 2014
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Prof Palmieri
Biomedical Research Centre
Imperial Clinical Trials Unit – Cancer (ICTU-Ca)
Imperial College Healthcare NHS Trust
Last reviewed: 14 November 2017
CRUK internal database number: 8041